pargyline has been researched along with sch 23390 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alfaro-Rodriguez, A; Alonso-Spilsbury, M; Arch-Tirado, E; Avila-Luna, A; Bueno-Nava, A; Gonzalez-Pina, R | 1 |
1 other study(ies) available for pargyline and sch 23390
Article | Year |
---|---|
The selective inhibition of the D₁ dopamine receptor results in an increase of metabolized dopamine in the rat striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Male; Pargyline; Rats; Rats, Wistar; Receptors, Dopamine D1 | 2012 |